Please wait while we open this resource.
K
Clinical reviews
LEFT VENTRICULAR-ARTERIAL COUPLING IN SEPTIC SHOCK: A PHYSIOLOGICAL REVIEW
Juan Daniel Caicedo Ruiz, Jose Luis Aldana, Eduardo Kattan, Nicolás Orozco, Gustavo García Gallardo, Jorge Iván Alvarado Sánchez, Juan José Diaztagle Fernández, Jihad Mallat, Gustavo Adolfo Ospina-Tascón
PDF9 pages3.8 MB
The review highlights the significance of LVAC in understanding cardiovascular dynamics during septic shock. It critiques traditional models that focus solely on cardiac contractility and venous return, arguing for a more integrated approach that considers arterial load. The authors explore the implications of LVAC for resuscitation and management strategies in septic patients, suggesting that a better understanding of this coupling can improve clinical outcomes.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CENTRAL VENOUS PRESSURE REVISITED: PHYSIOLOGY, PITFALLS, MISCONCEPTIONS, AND MODERN CLINICAL INTERPRETATION IN CRITICAL CARE
Same clinical topic · Critical Care
HOW I PERSONALIZE FLUID THERAPY IN SEPTIC SHOCK?
Same clinical topic · Critical Care
PRINCIPLES OF FLUID MANAGEMENT
Same clinical topic · Critical Care
ANEMIA OF CRITICAL ILLNESS: A CONCISE DEFINITIVE REVIEW IN CRITICAL CARE
Same clinical topic · Critical Care
NON-INTERVENTIONAL FOLLOW-UP VERSUS FLUID BOLUS IN RESPONSE TO OLIGURIA IN HEMODYNAMICALLY STABLE CRITICALLY ILL PATIENTS: A RANDOMIZED CONTROLLED PILOT TRIAL
Same clinical topic · Critical Care
LONG-TERM EFFECTS OF RESTRICTION OF INTRAVENOUS FLUID IN ADULT ICU PATIENTS WITH SEPTIC SHOCK
Same clinical topic · Critical Care
ASSOCIATION BETWEEN COMBINATION ANTIBIOTIC THERAPY AS OPPOSED TO MONOTHERAPY AND OUTCOMES OF ICU PATIENTS WITH PSEUDOMONAS AERUGINOSA VENTILATOR-ASSOCIATED PNEUMONIA: AN ANCILLARY STUDY OF THE IDIAPASON TRIAL
Same clinical topic · Critical Care
INTERFERON GAMMA - 1B FOR THE PREVENTION OF HOSPITAL - ACQUIRED PNEUMONIA IN CRITICALLY ILL PATIENTS: A PHASE 2, PLACEBO - CONTROLLED RANDOMIZED CLINICAL TRIAL
Same clinical topic · Critical Care
MANAGING THE PHYSIOLOGICALLY DIFFICULT AIRWAY IN CRITICALLY ILL ADULTS
Same clinical topic · Critical Care